PBOX 6 is primarily investigated for its potential applications in cancer research, particularly in the context of inducing apoptosis in cancer cells. It has shown promise in targeting and killing cancer cells while sparing normal, healthy cells, making it a candidate for chemotherapeutic development. Its mechanism involves disrupting microtubule dynamics, which is crucial for cell division, thereby inhibiting the proliferation of malignant cells. Researchers are exploring its efficacy in treating various types of cancers, including drug-resistant forms, to overcome limitations of existing treatments. Additionally, studies are ongoing to optimize its pharmacological properties for clinical use.